EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Digital nerve reconstruction with a new composite silk fibroin nerve conduit

Olga Politikou, Florian S. Frueh, Martina Greminger, Inga S. Besmens, Giuliano Freddi, Antonio Alessandrino, Maurizio Calcagni

Journal of the Peripheral Nervous System · 2025-03 · 30 (1)

DOI: 10.1111/jns.12675 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background and Aims Peripheral nerve injuries often require bridging when direct repair is not feasible. Nerve autografts are the gold standard, but they can lead to donor site morbidity. Silk fibroin‐based nerve conduits, like the novel SILKBridge, offer a promising alternative. This pilot study evaluates the mid‐term outcomes of the first in‐human digital nerve reconstruction using the SILKBridge, focusing on sensory recovery, complication rates, patient‐reported outcomes, and biological integration. Methods This study included four patients with digital nerve defects reconstructed using the SILKBridge. Clinical assessments included two‐point discrimination, Semmes–Weinstein monofilament testing, and pain evaluation using the Numeric Rating Scale. Sonographic assessments were also performed to evaluate the conduit's biointegration and potential complications. Results At a mean follow‐up of 32 months, all patients demonstrated satisfactory sensory recovery and reported minimal to no pain. Sonographic assessments confirmed effective biointegration with no signs of inflammation or scarring. Interpretation The mid‐term evaluation of the first in‐human digital nerve reconstruction with the SILKBridge revealed safety, efficiency, and favorable biocompatibility properties. Further studies with larger cohorts are needed to validate these findings and compare them with other nerve repair methods.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →